South African Medical News

Back to Home Page

Print using browser
NUVACO, Lamivudine, Tenofovir disoproxil, dolutegravir (Adcock Ingram)

adcocklogo2







Dear Healthcare Professional

Adcock Ingram are pleased to announce that NUVACO will be launched into the market as part of the Adcock Ingram ARV portfolio.

NUVACO contains dolutegravir 50 mg, lamivudine 300 mg and tenofovir disoproxil fumarate 300 mg.4 The recommended dose is one tablet daily in adults 18 years and older.4

Caution is advised when prescribing
NUVACO to women of child bearing age as there is an associated risk of neural tube defects to children exposed to (DTG/Nuvaco) during pregnancy.

Adcock Ingram believe in pursuing excellence in ART through their unwavering commitment to quality and affordability for people living with HIV.

Adcock Ingram is a proudly South African company with an unparalleled understanding of the needs of the South African HIV market.

Should you require any further information, please do not hesitate to contact your local representative or their
help-desk on 0860 ADCOCK (232625). 

Nuvaco 3D Pack

 
  • This is a drug - read the leaflet carefully before use 
  • Ask your doctor or pharmacist for further information.
For full prescribing information please refer to package insert approved by the Medical Regulatory authority.

References: 1. Meintjes G, Moorhouse MA, Carmona S, et al. Adult antiretroviral therapy guidelines 2017. S Afr J HIV Med. 2017;18(1), a776. https://doi.org/10.4102/ sajhivmed.v18i1.776. 2. Dlamini N. Health minister sees new ARV drug as breakthrough in fight against HIV. The South African National AIDS Council. 2 Oct 2017 [cited 03 July 2019]; Available from: http://sanac.org.za/2017/10/02/health-minister-sees-new-arv-drug-as-breakthrough-in-fight-against-hiv/. 3. Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV: interim guidance. Geneva: World Health Organization; July 2018 (WHO/CDS/HIV/18.18). Licence: CC BY-NC-SA 3.0 IGO. 4. NUVACO approved package insert, October 2018.

S4 Nuvaco film coated tablet. Each film-coated tablet contains Lamivudine 300 mg, Tenofovir disoproxil fumarate 300 mg, Dolutegravir sodium equivalent to dolutegravir 50 mg. Reg. No. 52/20.2.8/0949.

Adcock Ingram Limited. Reg. No. 1949/034385/06 Private Bag X69, Bryanston, 2021 Tel. + 27 11 635 0000.



You need to be logged in to see more details. Register Now!


Click here to visit the Adcock website.....
Contact: Tumi Motsei, Brand Manager: Prescription ARV's
Telephone: +27 (0) 11 635 0749
E-mail: Tumi.Motsei@adcock.com
Date: Thursday, August 15, 2019